Efficacy and safety of generic drugs of sotorasib

Sotorasib (AMG510, Sotorasib) As the first approved KRAS G12C mutation-specific inhibitor, it has created a new situation for targeting KRAS, a target that has long been considered "undruggable". With its widespread use in non-small cell lung cancer (NSCLC) and other KRAS G12C mutated tumors, market demand has grown rapidly, prompting some countries and regions to launch generic drugs of sotoraxib. These generic drugs usually have the same ingredients as the brand-name drugs and are designed to provide patients with more affordable treatment options, especially in areas with limited medical resources.

Take sotoracib produced by Lucius Pharmaceutical Factory in Laos as an example. Its main specifications are120mg*56 tablets. The price is about more than 1,000 yuan, which is much cheaper than the original drug, which greatly reduces the financial burden of patients. Despite the obvious price advantage, patients and doctors are still most concerned about the efficacy and safety of generic drugs. According to the approval standards for generic drugs by many overseas drug regulatory agencies, generic drugs must strictly comply with the original drug specifications in terms of drug ingredients, bioequivalence and production quality to ensure equivalent efficacy and safety. Therefore, there should be no significant difference between the content of active ingredients and release rate of compliant generic drugs of sotoraxib and the original drugs, and theoretically the efficacy should be comparable.

In terms of safety, the original drug of sotorasibu has been widely studied and applied. Common side effects include diarrhea, abnormal liver function, fatigue, etc. If a generic drug passes strict regulatory certification, its adverse reaction spectrum should be similar to that of the original drug. However, due to the different physiques and concomitant medications of individual patients, safety monitoring cannot be ignored. Patients should regularly review liver function and blood images during medication, and report abnormal reactions in a timely manner.

Taken together, generic drugs of sotoraxib play an important role in reducing treatment costs and improving drug accessibility. Its ingredients are basically the same as the original drug, and its efficacy and safety can be guaranteed under strict supervision.

Reference materials:https://www.lumakras.com/